Cargando…
Molecular recognition of the interaction between ApoE and the TREM2 protein
Alzheimer’s disease (AD) is the most common type of dementia. The ε4 allele of the apolipoprotein E (ApoE) gene is the strongest known genetic risk factor for late-onset AD. Triggering receptor expressed on myeloid cells 2 (TREM2) is another important risk factor affecting the AD process after ApoE....
Autores principales: | Mai, Zhenhua, Wei, Wenyan, Yu, Haibin, Chen, Yongze, Wang, Yongxiang, Ding, Yuanlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055258/ https://www.ncbi.nlm.nih.gov/pubmed/35582645 http://dx.doi.org/10.1515/tnsci-2022-0218 |
Ejemplares similares
-
Loss of TREM2 function increases amyloid seeding but reduces plaque associated ApoE
por: Parhizkar, Samira, et al.
Publicado: (2019) -
Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
por: Fitz, Nicholas F., et al.
Publicado: (2020) -
The Role of APOE and TREM2 in Alzheimer′s Disease—Current Understanding and Perspectives
por: Wolfe, Cody M., et al.
Publicado: (2018) -
APOE and TREM2 regulate amyloid responsive microglia in Alzheimer’s disease
por: Nguyen, Aivi T., et al.
Publicado: (2020) -
Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration
por: Franzmeier, Nicolai, et al.
Publicado: (2020)